On Invalid Date, Amgen (NASDAQ: AMGN) reported Q1 2024 earnings per share (EPS) of -$0.21, up 103.95% year over year. Total Amgen earnings for the quarter were -$113.00 million. In the same quarter last year, Amgen's earnings per share (EPS) was $5.32.
As of Q2 2024, Amgen's earnings has grown -52.46% year over year. This is 71.85 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 19.39%. Amgen's earnings in the past year totalled $3.76 billion.
What was AMGN's revenue last quarter?
On Invalid Date, Amgen (NASDAQ: AMGN) reported Q1 2024 revenue of $7.45 billion up 21.98% year over year. In the same quarter last year, Amgen's revenue was $6.11 billion.
What was AMGN's revenue growth in the past year?
As of Q2 2024, Amgen's revenue has grown 12.76% year over year. This is 3.77 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 8.99%. Amgen's revenue in the past year totalled $29.53 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.